Morphochem Aktiengesellschaft für kombinatorische Chemie is a private clinical-stage pharmaceutical company located in Munich, Germany. Morphochem is a 100-percent subsidiary of Biovertis AG, headquartered in Vienna, Austria. Biovertis's major shareholder is TVM Capital Life Science.
Looking for a particular Morphochem AG employee's phone or email?
The Morphochem AG annual revenue was $9 million in 2026.
Peter Seufer-Wasserthal is the Vice President Business Development of Morphochem AG.
1 people are employed at Morphochem AG.
The NAICS codes for Morphochem AG are [32541, 3254, 325, 32].
The SIC codes for Morphochem AG are [2834, 28, 283].